Subscribe for PTCOG-NA Updates
Bradford Hoppe, M.D., MPH, is a Professor of Radiation Oncology and the Medical Director of Particle Therapy in Mayo Clinic, Jacksonville, FL. He graduated from Cornell University Medical College and went on to do his training in radiation oncology at Memorial Sloan Kettering Cancer Center in NYC. Following residency, Dr. Hoppe worked at University of Florida for 11 years, where he was the James Lockwood endowed Professor of Proton therapy. In 2019, he was recruited by Mayo Clinic Florida to be the Particle Therapy Medical Director.
Dr. Hoppe is an international expert in particle therapy and lymphoma, serving on the steering committees for PTCOG-NA, ILROG, and the COG pediatric Hodgkin lymphoma. His research interests focus on improving therapeutic ratio in the management of lymphoma and solid cancers by reducing the risk of toxicities from radiation, while simultaneously trying to improve cure and overall survival with proton therapy. His contributions have helped shape the national management guidelines for prostate cancer, lymphoma, and lung cancer.
Stella Flampouri is a medical physicist at the Emory Proton Therapy Center in Atlanta, GA. She trained in physics at the University of Athens, Greece and received her MSc in bioengineering from Imperial College, London. She obtained her PhD in medical physics from the Institute of Cancer Research and Royal Marsden Hospital, UK. Starting with her work as a fellow at Massachusetts General Hospital she has focused on lung radiotherapy. She was the leading physicist of the thoracic service at the University of Florida Proton Therapy Institute for 10 years before moving to Emory where she still oversees the lung proton therapy physics. She has multiple publications on thoracic radiation therapy and is a member of the AAPM task group on Respiratory Motion Management for Particle Therapy as well as the PTCOG thoracic subcommittee.